Ventritex's IPO

Ventritex raised a round of funding on January 01, 1993. Investors include Public.

Ventritex is marketed as a minimally invasive diagnostic system for mapping arrhythmias, potentially fatal or life debilitating heart rhythms.…

Articles about Ventritex's IPO: